MilliporeSigma’s New Microbial Bioburden Testing System Offers Enhanced Results and Increased Productivity
Pharmaceutical Technology's In the Lab eNewsletter
The company’s new Milliflex Oasis System provides enhanced result reliability, increased productivity, and advanced traceability.
MilliporeSigma’s latest innovation, the Milliflex Oasis System, offers enhanced benefits for pharmaceutical bioburden and water testing. It has 96 new features to increase result reliability and traceability while streamlining the bioburden testing workflow, the company reports.
The benefits of the new system include:
- Operator-independent handling steps, improved touch-free membrane transfer with color-coded components for increased result reliability
- 50% faster filtration time compared with previous product generation
- Scalable hardware for high throughput
- Reduced decontamination and maintenance time for optimized productivity
- 2-dimensional codes and labels on primary and secondary packaging, on each funnel and media plate, for traceability and regulation compliance
The system also offers an all-in-one filtration solution with sterilized, ready-to-use filtration units and pharmacopeia-compliant media for comfort and peace of mind for water and bioburden testing, according to the company. MilliporeSigma launched the Milliflex Oasis System on Jan. 29, 2020.
Source: MilliporeSigma
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
